Prospective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Prediction of Death at 1 Month Among Patients With Septic Shock
NCT01231672 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 780
Last updated 2025-11-17
Summary
A prognostic score was proposed by the investigative team to predict death at 1 month. This score is based on certain biological markers, scored under emergency conditions in the first 24 hours of routine clinical practice management for septic shock.
The main objective of this multicenter study is to validate the performance of the score in terms of area under the ROC curve and negative predictive value.
Conditions
- Shock, Septic
Interventions
- BIOLOGICAL
-
Routine biological analyses
Bilirubinemia (total and conjugated), hematology, hemogram, SOFA score
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nīmes
lead OTHER
Principal Investigators
-
Géraldine Lavigne-Lissalde, MD · Centre Hospitalier Universitaire de Nîmes
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2013-10-30
- Completion
- 2013-10-30
Countries
- France
Study Locations
More Related Trials
-
Evaluation of the Performance of Sepsis Predictive Scores on the Elderly Population in the Emergency Department.
NCT04721275 ·Status: UNKNOWN
-
Relation Between Mean Arterial Pressure and Renal Resistive Index in the Early Phase of Septic Shock
NCT04281277 ·Status: COMPLETED ·Phase: NA
-
Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients
NCT07234526 ·Status: NOT_YET_RECRUITING
-
Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
NCT06446947 ·Status: RECRUITING
-
Venous to Arterial Carbon Dioxide Difference (P₍ᵥ-ₐ₎CO₂): Predictor of Septic Patient Prognosis Depending on the ScvO₂
NCT03292120 ·Status: COMPLETED ·Phase: NA
-
Septic Shock-induced Immunosuppression
NCT04067674 ·Status: RECRUITING
-
Epidemiology of Septic Shock in Medical or Polyvalent ICU in the North-East Region of France
NCT01903746 ·Status: TERMINATED
-
Comparing Prognostic Performance of SEPSIS 2 and SEPSIS 3 Strategies at the Emergency Service
NCT03355833 ·Status: COMPLETED
-
Endotoxin in Gram-negative Septic Shock
NCT01602354 ·Status: UNKNOWN
-
Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?
NCT02116413 ·Status: COMPLETED
-
A Prediction Model of 28-day Mortality in Septic Shock
NCT04915625 ·Status: UNKNOWN
-
Assessment of Two Levels of Arterial Pressure on Survival in Patients With Septic Shock
NCT01149278 ·Status: COMPLETED ·Phase: NA
-
Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
NCT01841190 ·Status: UNKNOWN
-
Correlation of VEGF-A and Fluid Balance in Septic Shock
NCT04474431 ·Status: COMPLETED ·Phase: NA
-
Comparing an Automated to a Conventional Sepsis Clinical Prediction Rule
NCT01505478 ·Status: WITHDRAWN
-
Strain Echocardiography During Septic Shock : an Observational Pilot Study
NCT03663192 ·Status: COMPLETED
-
Shock Indices Use for Early Mortality From Septic Shock
NCT05088109 ·Status: UNKNOWN
-
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400 ·Status: UNKNOWN
-
Evolution of Tissue Perfusion and Venous Congestion Markers in Fluid-Responsive Septic Shock Patients
NCT06958809 ·Status: NOT_YET_RECRUITING
-
Early Albumin Resuscitation During Septic Shock
NCT00327704 ·Status: COMPLETED ·Phase: PHASE4
-
Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological Markers
NCT02692053 ·Status: UNKNOWN ·Phase: NA
-
Mortality Due to Septic Shock Associated With Thrombocytopenia
NCT03617965 ·Status: UNKNOWN
-
Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction
NCT07124741 ·Status: NOT_YET_RECRUITING
-
Hemodynamic Evaluation Using Microcirculation for Early Treatment of Septic Patients
NCT06910891 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN